Navigation Links
Generex Common Stock to be Quoted on the OTCQB Under the Symbol 'GNBT' Beginning Thursday, October 21, 2010
Date:10/19/2010

WORCESTER, Mass., Oct. 19 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (www.generex.com) announced today that on October 19, 2010 the NASDAQ Listing Qualifications Panel notified the Company that the Panel has determined to delist the Company's common stock from the NASDAQ Capital Market and will suspend trading of the stock effective at the open of trading on Thursday, October 21, 2010 as a consequence of the Company's non-compliance with NASDAQ's minimum $1.00 per share closing bid price requirement.

The Company has been advised by Pink OTC Markets Inc., which operates an electronic quotation service for securities traded over-the-counter (OTC), that the Company's common stock is immediately eligible for quotation on the OTCQB effective with the opening of the markets on October 21, 2010.  The OTCQB is a market tier for OTC traded companies that are registered and reporting with the Securities and Exchange Commission.  The Company has also been advised that its common stock will continue to trade under the symbol "GNBT".  Investors will be able to view real time stock quotes for GNBT at http://www.otcmarkets.com.

In September, 2010, there were 3,871 securities quoted on the OTCQB and the aggregate dollar value traded was just under $4 billion.

Generex management and its Board of Directors remain fully committed to the aggressive pursuit of the Company's product development and commercialization initiatives.  "The move to the OTCQB is not reflective of the value and tremendous potential of our pipeline," said Mark Fletcher, the Generex Interim President & Chief Executive Officer.  "Our efforts to move our pipeline products forward to commercialization will continue unabated."

At the reconvened Special Meeting of the Company's stockholders held on October 18, 2010, the reverse stock split proposal put forward by t
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
2. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
3. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
4. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
5. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
6. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
7. deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma
8. Delcath Systems Announces the Sale of 5,185,000 Shares of Common Stock
9. PDL BioPharma Announces Retirement of $61.6 Million of 2.75% Convertible Notes due August 2023 for Common Stock
10. Advanced Life Sciences CEO Acquires $2 Million of Common Stock Through Debt for Equity Exchange
11. DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... CIRTEC Medical Systems , a ... complex Class III implantable devices and minimally invasive devices, ... initiative aimed at identifying potentially marketable biomedical technologies developed ... moving them more efficiently from the laboratory bench to ... working with the world's largest OEMs and most innovative ...
(Date:6/3/2015)... ROOSEVELT, N.J. , June 3, 2015 /PRNewswire/ ... Life Science industries, will host its 6 th ... and Exposition Center at Raritan Center in ... 2015.  Event sponsors include Novo Nordisk, Covance, Actavis ... companies that will be exhibiting are Johnson & ...
(Date:6/3/2015)... Roanoke, Virginia (PRWEB) June 03, 2015 ... officially changed its name to PogoTec™, Inc. ( ... of its electronic wearable device products and technologies it ... the creation of three business divisions, PogoTec™ will provide ... wearable devices as follows: , , ...
(Date:6/3/2015)... Marktech Optoelectronics is pleased to introduce a ... an internal gain mechanism, fast time response, low dark ... These APD’s are recommended for applications that require high ... high pre-amp noise. In addition, Marktech APD's provide higher ... extreme low-level light detection and short pulse detection. ...
Breaking Biology Technology:CIRTEC Medical Systems to support new UT Dallas-led Initiative to deliver biomedical technologies from laboratory bench to bedside more efficiently 2AstraZeneca Added as Sponsor for Industry Leading Life Science Hiring Event 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 3Marktech Introduces New Line of APDs 2
... Conn., May 20 Biodel Inc. (Nasdaq:,BIOD) today announced ... Chief Medical Officer, effective May 27, 2008., "The ... with strong,internal clinical and regulatory leadership and we expect ... of our product candidates," said,Dr. Solomon Steiner, Chief Executive ...
... McHENRY, Ill., May 20 Turtle Island ... Food soups fortified with ingredients shown to ... ( http://www.ganedenlabs.com/index.html )., The new Souper ... GanedenBC30,(Bacillus coagulans GBI-30, 6086),( http://www.ganedenlabs.com/ourScience.html ), a ...
... of Two-Phase Examination of U.S. Asthma Control, RESEARCH ... half of adult Americans with asthma and more than ... nationally representative survey do,not have their disease well controlled, ... at the International Conference of the American,Thoracic Society meeting ...
Cached Biology Technology:Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer 2Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 2Turtle Island Soup Gets 'Souped Up' with New Probiotic, GandenBC30 3Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 2Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 3
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... -- Curemark LLC, a privately held drug research and ... III double blind, randomized, placebo-controlled clinical trial to examine ... children ages 3-8 with Autism. Previously, Curemark announced the ... clinical trial for CM-AT in children ages 3-8 with ... chymotrypsin. This new trial will help determine whether all ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... The NIH Neuroscience Microarray Consortium today announced that ... Affymetrix and Illumina platforms to its list of ... says that "adding ultra-high throughput genotyping for its ... the Consortium current with the demands of the ...
... Genetics tests could help provide cystic fibrosis (CF) ... authors suggest. Results from a French clinical trial ... small percentage of CF sufferers with a rare ... , Aleksander Edelman and Isabelle Sermet-Gaudelus of Faculté ...
... good with puzzles or chess, the reason may be in ... psychiatric geneticists at Washington University School of Medicine in St. ... a gene that activates signaling pathways in the brain influences ... the gene, CHRM2, and performance IQ, which involves a person's ...
Cached Biology News:NIH neuroscience microarray consortium launches high-throughput genotyping services 2Genes and genius: Researchers confirm association between gene and intelligence 2Genes and genius: Researchers confirm association between gene and intelligence 3
Goat polyclonal to Lipocalin 2...
... encodes two unrelated proteins both of which ... cell cycle in a p53-dependent manner. p14^ARF^ ... degradation of mdm2 proteinrequired for mdm2 modification ... This interaction is mediated by the exon ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... its effects by binding ... a disulfide-linked heterotetrameric protein ... subunits and two Beta ... following configuration: Beta-Alpha-Alpha-Beta. ...
Biology Products: